Welcoming a nominee during a committee meeting.
11/19/2014
https://www.congress.gov...
Wow. Well, you know, we must ensure that drug companies do not rely on tricks in order to avoid competition.
Or we can spend nearly a trillion dollars in overpayments to insurance companies for crummy coverage that beneficiaries do not use.
The name of the game is volume. The more volume a drug company has with a particular PBM, and the greater the drug company's market share, t...